Document is current
Any future updates will be listed below
-
Authors
Ibrahim, Ziad
Wang, Tao
Destaing, Olivier https://orcid.org/0000-0001-7622-3700
Salvi, Nicola https://orcid.org/0000-0003-1515-6908
Hoghoughi, Naghmeh
Chabert, Clovis
Rusu, Alexandra
Gao, Jinjun
Feletto, Leonardo
Reynoird, Nicolas https://orcid.org/0000-0003-1578-2781
Schalch, Thomas
Zhao, Yingming
Blackledge, Martin https://orcid.org/0000-0003-0935-721X
Khochbin, Saadi https://orcid.org/0000-0002-0455-0857
Panne, Daniel https://orcid.org/0000-0001-9158-5507
-
Funding
Funding for this research was provided by:
Wellcome Trust (221881/Z/20/Z)
RCUK | Medical Research Council (MR/W001667/1)
Worldwide Cancer Research (16-0280)
Instruct-ERIC [PID: 18571]
- License Information
-
More Information
Article History
Received: 25 July 2022
Accepted: 29 November 2022
First Online: 15 December 2022
Competing interests
: Y.Z. is a founder, board member, advisor to, and inventor on patents licensed to PTM Biolabs Inc (Hangzhou, China and Chicago, IL) and Maponos Therapeutics Inc. (Chicago, IL). The other authors declare no competing interests.
